MOLECULAR BIOSYSTEMS INC
8-K, EX-23.1, 2001-01-16
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MOLECULAR BIOSYSTEMS INC, 8-K, 2001-01-16
Next: MOLECULAR BIOSYSTEMS INC, 8-K, EX-99.1, 2001-01-16



<PAGE>

                 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


     As independent public accountants, we hereby consent to the
incorporation of our report dated May 10, 2000 of Molecular Biosystems, Inc.
included in this Form 8-K into Alliance Pharmaceutical Corp.'s previously
filed registration statements on Forms S-3 and S-8.

Arthur Andersen LLP

/s/ Arthur Andersen LLP

San Diego, CA
January 12, 2001






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission